- Home
- PULM vs EPOW Comparison
PULM vs EPOW Comparison
Compare PULM & EPOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- EPOW
- Stock Information
- Founded
- PULM 2003
- EPOW 2014
- Country
- PULM United States
- EPOW China
- Employees
- PULM N/A
- EPOW N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- EPOW Business Services
- Sector
- PULM Health Care
- EPOW Consumer Discretionary
- Exchange
- PULM Nasdaq
- EPOW Nasdaq
- Market Cap
- PULM 33.2M
- EPOW 24.5M
- IPO Year
- PULM N/A
- EPOW 2021
- Fundamental
- Price
- PULM $6.21
- EPOW $0.90
- Analyst Decision
- PULM
- EPOW
- Analyst Count
- PULM 0
- EPOW 0
- Target Price
- PULM N/A
- EPOW N/A
- AVG Volume (30 Days)
- PULM 55.4K
- EPOW 18.0K
- Earning Date
- PULM 08-12-2025
- EPOW 07-29-2025
- Dividend Yield
- PULM N/A
- EPOW N/A
- EPS Growth
- PULM N/A
- EPOW N/A
- EPS
- PULM N/A
- EPOW N/A
- Revenue
- PULM $1,921,000.00
- EPOW $64,997,741.00
- Revenue This Year
- PULM N/A
- EPOW N/A
- Revenue Next Year
- PULM $134.88
- EPOW N/A
- P/E Ratio
- PULM N/A
- EPOW N/A
- Revenue Growth
- PULM N/A
- EPOW 44.28
- 52 Week Low
- PULM $1.78
- EPOW $0.55
- 52 Week High
- PULM $10.40
- EPOW $1.36
- Technical
- Relative Strength Index (RSI)
- PULM 41.32
- EPOW 47.21
- Support Level
- PULM $6.10
- EPOW $0.88
- Resistance Level
- PULM $6.83
- EPOW $0.96
- Average True Range (ATR)
- PULM 0.33
- EPOW 0.06
- MACD
- PULM -0.05
- EPOW -0.00
- Stochastic Oscillator
- PULM 21.00
- EPOW 25.40
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.